ACADIA PHARMACEUTICALS INC. Increase (Decrease) in Accounts Receivable and Other Operating Assets
ACADIA PHARMACEUTICALS INC. (ACAD) reported Increase (Decrease) in Accounts Receivable and Other Operating Assets of -$11.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2026-06-30 was $2.66M, a 36.82% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2026-03-31 was -$13.74M, a 781.89% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2025-12-31 was $3.19M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2025-09-30 was $11.40M, a 108.85% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2025 was $20.82M, a 1011.48% increase from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2024 was $1.87M, a 41.43% decline from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2023 was $3.20M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2022 was -$93.00K.
| Period end | Increase (Decrease) in Accounts Receivable and Other Operating Assets 3 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 6 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 9 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$11.08M 10-Q · filed 2026-08-05 | -$7.89M derived: sum of 3 quarters · filed 2026-08-05 | $3.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$13.74M 10-Q · filed 2026-05-07 | -$10.55M derived: sum of 2 quarters · filed 2026-05-07 | $853.00K derived: sum of 3 quarters · filed 2026-05-07 | $5.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.59M derived: sum of 2 quarters · filed 2026-02-26 | $18.80M derived: sum of 3 quarters · filed 2026-08-05 | $20.82M 10-K · filed 2026-02-26 |
| 2025-09-30 | $11.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.61M derived: sum of 2 quarters · filed 2026-08-05 | $17.63M 10-Q · filed 2025-11-06 | $11.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.22M 10-Q · filed 2026-08-05 | $27.00K derived: sum of 3 quarters · filed 2026-08-05 | $5.49M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.02M 10-Q · filed 2026-05-07 | -$4.18M derived: sum of 2 quarters · filed 2026-05-07 | $1.28M derived: sum of 3 quarters · filed 2026-05-07 | $2.59M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$739.00K derived: sum of 2 quarters · filed 2026-02-26 | $578.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.87M 10-K · filed 2026-02-26 |
| 2024-09-30 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.78M derived: sum of 2 quarters · filed 2025-11-06 | $8.07M 10-Q · filed 2025-11-06 | $10.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.61M 10-Q · filed 2025-08-07 | $4.96M derived: sum of 3 quarters · filed 2026-02-26 | $4.39M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.29M 10-Q · filed 2025-05-08 | $3.65M derived: sum of 2 quarters · filed 2026-02-26 | $3.07M derived: sum of 3 quarters · filed 2026-02-26 | $1.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.78M derived: sum of 2 quarters · filed 2026-02-26 | -$252.00K derived: sum of 3 quarters · filed 2026-02-26 | $3.20M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$574.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.60M derived: sum of 2 quarters · filed 2024-11-07 | $845.00K 10-Q · filed 2024-11-07 | $1.33M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.42M 10-Q · filed 2024-08-07 | $1.90M derived: sum of 3 quarters · filed 2025-02-27 | $1.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.45M 10-Q · filed 2024-05-09 | $3.93M derived: sum of 2 quarters · filed 2025-02-27 | $3.40M derived: sum of 3 quarters · filed 2025-02-27 | $3.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$51.00K derived: sum of 2 quarters · filed 2025-02-27 | $116.00K derived: sum of 3 quarters · filed 2025-02-27 | -$93.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$366.00K derived: sum of 2 quarters · filed 2023-11-03 | -$575.00K 10-Q · filed 2023-11-03 | -$569.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$42.00K 10-Q · filed 2023-08-03 | -$36.00K derived: sum of 3 quarters · filed 2024-02-28 | $483.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$209.00K 10-Q · filed 2023-05-08 | -$203.00K derived: sum of 2 quarters · filed 2024-02-28 | $316.00K derived: sum of 3 quarters · filed 2024-02-28 | $211.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $525.00K derived: sum of 2 quarters · filed 2024-02-28 | $420.00K derived: sum of 3 quarters · filed 2024-02-28 | -$1.06M 10-K · filed 2024-02-28 |
| 2021-09-30 | $519.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $414.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.06M 10-Q · filed 2022-11-03 | -$468.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.58M 10-Q · filed 2022-08-09 | -$987.00K derived: sum of 3 quarters · filed 2023-02-28 | -$1.89M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.48M 10-Q · filed 2022-05-05 | -$882.00K derived: sum of 2 quarters · filed 2023-02-28 | -$1.78M derived: sum of 3 quarters · filed 2023-02-28 | -$2.38M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$308.00K derived: sum of 2 quarters · filed 2023-02-28 | -$900.00K derived: sum of 3 quarters · filed 2023-02-28 | -$58.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | -$903.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.50M derived: sum of 2 quarters · filed 2021-11-09 | -$653.00K 10-Q · filed 2021-11-09 | -$25.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $250.00K 10-Q · filed 2021-08-05 | $878.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.40M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $842.00K 10-Q · filed 2021-05-06 | $1.47M derived: sum of 2 quarters · filed 2022-03-01 | $1.99M derived: sum of 3 quarters · filed 2022-03-01 | -$877.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.15M derived: sum of 2 quarters · filed 2022-03-01 | -$1.72M derived: sum of 3 quarters · filed 2022-03-01 | $394.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $524.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$2.35M derived: sum of 2 quarters · filed 2020-11-04 | -$234.00K 10-Q · filed 2020-11-04 | $741.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$758.00K 10-Q · filed 2020-08-06 | $217.00K derived: sum of 3 quarters · filed 2021-02-25 | -$45.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.11M 10-Q · filed 2020-05-08 | $3.09M derived: sum of 2 quarters · filed 2021-02-25 | $2.83M derived: sum of 3 quarters · filed 2021-02-25 | $2.91M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $975.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $713.00K derived: sum of 2 quarters · filed 2021-02-25 | $796.00K derived: sum of 3 quarters · filed 2021-02-25 | $612.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | -$262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$179.00K derived: sum of 2 quarters · filed 2019-10-31 | -$363.00K 10-Q · filed 2019-10-31 | -$309.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$101.00K 10-Q · filed 2019-08-01 | -$47.00K derived: sum of 3 quarters · filed 2020-02-27 | $202.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$184.00K 10-Q · filed 2019-05-02 | -$130.00K derived: sum of 2 quarters · filed 2020-02-27 | $119.00K derived: sum of 3 quarters · filed 2020-02-27 | -$956.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $303.00K derived: sum of 2 quarters · filed 2020-02-27 | -$772.00K derived: sum of 3 quarters · filed 2020-02-27 | -$150.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$826.00K derived: sum of 2 quarters · filed 2018-11-06 | -$204.00K 10-Q · filed 2018-11-06 | -$352.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$453.00K 10-Q · filed 2018-08-08 | -$601.00K derived: sum of 3 quarters · filed 2019-02-27 | -$556.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $622.00K 10-Q · filed 2018-05-04 | $474.00K derived: sum of 2 quarters · filed 2019-02-27 | $519.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.08M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$103.00K derived: sum of 2 quarters · filed 2019-02-27 | $454.00K derived: sum of 3 quarters · filed 2019-02-27 | -$401.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $602.00K derived: sum of 2 quarters · filed 2017-11-07 | -$253.00K 10-Q · filed 2017-11-07 | $1.18M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$298.00K 10-Q · filed 2017-08-08 | $1.13M derived: sum of 3 quarters · filed 2018-02-27 | -$168.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$855.00K 10-Q · filed 2017-05-09 | $577.00K derived: sum of 2 quarters · filed 2018-02-27 | -$725.00K derived: sum of 3 quarters · filed 2018-02-27 | $37.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $130.00K derived: sum of 2 quarters · filed 2018-02-27 | $892.00K derived: sum of 3 quarters · filed 2018-02-27 | $674.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$540.00K derived: sum of 2 quarters · filed 2016-11-07 | -$758.00K 10-Q · filed 2016-11-07 | -$933.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $762.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $544.00K 10-Q · filed 2016-08-04 | $369.00K derived: sum of 3 quarters · filed 2017-02-28 | $188.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$218.00K 10-Q · filed 2016-05-05 | -$393.00K derived: sum of 2 quarters · filed 2017-02-28 | -$574.00K derived: sum of 3 quarters · filed 2017-02-28 | -$896.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$356.00K derived: sum of 2 quarters · filed 2017-02-28 | -$678.00K derived: sum of 3 quarters · filed 2017-02-28 | $214.00K 10-K · filed 2017-02-28 |
| 2014-09-30 | -$181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$503.00K derived: sum of 2 quarters · filed 2015-11-05 | $389.00K 10-Q · filed 2015-11-05 | $178.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $570.00K 10-Q · filed 2015-08-06 | $359.00K derived: sum of 3 quarters · filed 2016-02-29 | $519.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $892.00K 10-Q · filed 2015-05-07 | $681.00K derived: sum of 2 quarters · filed 2016-02-29 | $841.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.22M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$51.00K derived: sum of 2 quarters · filed 2016-02-29 | $325.00K derived: sum of 3 quarters · filed 2016-02-29 | $505.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $536.00K derived: sum of 2 quarters · filed 2014-11-10 | $716.00K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $556.00K 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | $180.00K 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | -$279.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |